Japan Generic Drugs Industry Report 2015

August 2015 | 271 pages | ID: JA5DB5DC401EN
QYResearch

Abstracts

The Japan Generic Drugs Industry Report 2015 is a professional and in-depth study on the current state of the Generic Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Generic Drugs market analysis is provided for the Japan markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on Japan major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Generic Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 281 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

CHAPTER ONE INDUSTRY OVERVIEW

1.1 Definition and Specifications of Generic Drugs
1.2 Classification of Generic Drugs
1.3 Applications of Generic Drugs
1.4 Industry Chain Structure of Generic Drugs
1.5 Industry Overview of Generic Drugs
1.6 Industry Policy Analysis of Generic Drugs
1.7 Industry News Analysis of Generic Drugs

CHAPTER TWO MANUFACTURING COST STRUCTURE ANALYSIS OF GENERIC DRUGS

2.1 Bill of Materials (BOM) of Generic Drugs
2.2 BOM Price Analysis of Generic Drugs
2.3 Labor Cost Analysis of Generic Drugs
2.4 Depreciation Cost Analysis of Generic Drugs
2.5 Manufacturing Cost Structure Analysis of Generic Drugs
2.6 Manufacturing Process Analysis of Generic Drugs

CHAPTER THREE TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS

3.1 Capacity and Commercial Production Date of Japan Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Japan Key Generic Drugs Manufacturers in 2014
3.3 R&D Status and Technology Source of Japan Generic Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Japan Generic Drugs Key Manufacturers in 2014

CHAPTER FOUR PRODUCTION ANALYSIS OF GENERIC DRUGS BY REGIONS, TECHNOLOGY, AND APPLICATIONS

4.1 Japan Production of Generic Drugs by Regions (Key Provinces) 2010-2015
4.2 Japan Production of Generic Drugs by Product Types 2010-2015
4.3 Japan Sales of Generic Drugs by Applications 2010-2015
4.4 Price Analysis of Japan Generic Drugs Key Manufacturers in 2015
4.5 Japan Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Generic Drugs 2010-2015

CHAPTER FIVE SALES AND REVENUE ANALYSIS OF GENERIC DRUGS BY REGIONS

5.1 Japan Sales of Generic Drugs by Regions 2010-2015
5.2 Japan Revenue of Generic Drugs by Regions 2010-2015
5.3 Japan Price Analysis of Generic Drugs Sales by Regions 2010-2015
5.4 Japan Price, Cost and Gross of Generic Drugs 2010-2015

CHAPTER SIX ANALYSIS OF GENERIC DRUGS PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2010-2015

6.1 Capacity Production Sales Revenue of Generic Drugs 2010-2015
6.2 Production Sales Market Share Analysis of Generic Drugs 2014-2015
6.3 Import, Export and Consumption of Generic Drugs 2010-2015
6.4 Supply, Consumption and Shortage of Generic Drugs 2010-2015
6.5 Import, Export and Consumption of Generic Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Generic Drugs 2010-2015

CHAPTER SEVEN ANALYSIS OF GENERIC DRUGS INDUSTRY KEY MANUFACTURERS

7.1 Sawai Pharmaceuticals
  7.1.1 Company Profile
  7.1.2 Product Picture and Specification
  7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.1.4 Sawai Pharmaceuticals SWOT Analysis
7.2 Meiji Seika Pharma
  7.2.1 Company Profile
  7.2.2 Product Picture and Specification
  7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.2.4 Meiji Seika Pharma SWOT Analysis
7.3 Nipro Pharma
  7.3.1 Company Profile
  7.3.2 Product Picture and Specification
  7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.3.4 Nipro Pharma SWOT Analysis
7.4 Towa Pharmaceutical
  7.4.1 Company Profile
  7.4.2 Product Picture and Specification
  7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.4.4 Towa Pharmaceutical SWOT Analysis
7.5 Teva Pharmaceutical Industries
  7.5.1 Company Profile
  7.5.2 Product Picture and Specification
  7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.5.4 Teva Pharmaceutical Industries SWOT Analysis
7.6 Nichi-Iko Pharmaceutical
  7.6.1 Company Profile
  7.6.2 Product Picture and Specification
  7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.6.4 Nichi-Iko Pharmaceutical SWOT Analysis
7.7 Fuji Pharma
  7.7.1 Company Profile
  7.7.2 Product Picture and Specification
  7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.7.4 Fuji Pharma SWOT Analysis
7.8 GlaxoSmithKline
  7.8.1 Company Profile
  7.8.2 Product Picture and Specification
  7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.8.4 GlaxoSmithKline SWOT Analysis
7.9 Hikari Pharmaceutical
  7.9.1 Company Profile
  7.9.2 Product Picture and Specification
  7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.9.4 Hikari Pharmaceutical SWOT Analysis
7.10 Hospira
  7.10.1 Company Profile
  7.10.2 Product Picture and Specification
  7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.10.4 Hospira SWOT Analysis
7.11 Mylan
  7.11.1 Company Profile
  7.11.2 Product Picture and Specification
  7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.11.4 Mylan SWOT Analysis
7.12 Nihon Generic
  7.12.1 Company Profile
  7.12.2 Product Picture and Specification
  7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.12.4 Nihon Generic SWOT Analysis
7.13 Nippon Chemipher
  7.13.1 Company Profile
  7.13.2 Product Picture and Specification
  7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.13.4 Nippon Chemipher SWOT Analysis
7.14 Nippon Kayaku
  7.14.1 Company Profile
  7.14.2 Product Picture and Specification
  7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.14.4 Nippon Kayaku SWOT Analysis
7.15 Nissin Pharmaceutical
  7.15.1 Company Profile
  7.15.2 Product Picture and Specification
  7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.15.4 Nissin Pharmaceutical SWOT Analysis
7.16 Actavis
  7.16.1 Company Profile
  7.16.2 Product Picture and Specification
  7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.16.4 Actavis SWOT Analysis
7.17 Daiichi Sankyo
  7.17.1 Company Profile
  7.17.2 Product Picture and Specification
  7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.17.4 Daiichi Sankyo SWOT Analysis
7.18 Daito Pharmaceutical
  7.18.1 Company Profile
  7.18.2 Product Picture and Specification
  7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.18.4 Daito Pharmaceutical SWOT Analysis
7.19 Eisai
  7.19.1 Company Profile
  7.19.2 Product Picture and Specification
  7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.19.4 Eisai SWOT Analysis
7.20 Ohara Pharmaceutical
  7.20.1 Company Profile
  7.20.2 Product Picture and Specification
  7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.20.4 Ohara Pharmaceutical SWOT Analysis
7.21 Pfizer
  7.21.1 Company Profile
  7.21.2 Product Picture and Specification
  7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.21.4 Pfizer SWOT Analysis
7.22 Sandoz
  7.22.1 Company Profile
  7.22.2 Product Picture and Specification
  7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.22.4 Sandoz SWOT Analysis
7.23 Taiyo Yakuhin
  7.23.1 Company Profile
  7.23.2 Product Picture and Specification
  7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.23.4 Taiyo Yakuhin SWOT Analysis
7.24 Takeda Pharmaceutical
  7.24.1 Company Profile
  7.24.2 Product Picture and Specification
  7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.24.4 Takeda Pharmaceutical SWOT Analysis
7.25 Zensei Pharmaceutical Industries
  7.25.1 Company Profile
  7.25.2 Product Picture and Specification
  7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
  7.25.4 Zensei Pharmaceutical Industries SWOT Analysis

CHAPTER EIGHT PRICE AND GROSS MARGIN ANALYSIS

8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Generic Drugs Product Types
8.5 Market Share Analysis of Different Generic Drugs Price Levels
8.6 Gross Margin Analysis of Different Generic Drugs Applications

CHAPTER NINE MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF GENERIC DRUGS

9.1 Marketing Channels Status of Generic Drugs
9.2 Traders or Distributors of Generic Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Generic Drugs
9.4 Japan Import, Export and Trade Analysis of Generic Drugs

CHAPTER TEN DEVELOPMENT TREND OF GENERIC DRUGS INDUSTRY 2015-2020

10.1 Capacity and Production Overview of Generic Drugs 2015-2020
10.2 Production Market Share by Product Types of Generic Drugs 2015-2020
10.3 Sales and Sales Revenue Overview of Generic Drugs 2015-2020
10.4 Japan Sales of Generic Drugs by Applications 2015-2020
10.5 Import, Export and Consumption of Generic Drugs 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Generic Drugs 2015-2020

CHAPTER ELEVEN INDUSTRY CHAIN SUPPLIERS OF GENERIC DRUGS WITH CONTACT INFORMATION

11.1 Major Raw Materials Suppliers of Generic Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Generic Drugs with Contact Information
11.3 Major Players of Generic Drugs with Contact Information
11.4 Key Consumers of Generic Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Generic Drugs

CHAPTER TWELVE NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF GENERIC DRUGS

12.1 New Project SWOT Analysis of Generic Drugs
12.2 New Project Investment Feasibility Analysis of Generic Drugs

CHAPTER THIRTEEN CONCLUSION OF THE JAPAN GENERIC DRUGS INDUSTRY REPORT 2015

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Generic Drugs
Table Product Specifications of Generic Drugs
Table Classification of Generic Drugs
Figure Japan Sales Market Share of Generic Drugs by Product Types in 2014
Table Applications of Generic Drugs
Figure Japan Sales Market Share of Generic Drugs by Applications in 2014
Figure Industry Chain Structure of Generic Drugs
Table Japan Industry Overview of Generic Drugs
Table Industry Policy of Generic Drugs
Table Industry News List of Generic Drugs
Table Bill of Materials (BOM) of Generic Drugs
Table Bill of Materials (BOM) Price of Generic Drugs
Table Labor Cost of Generic Drugs
Table Depreciation Cost of Generic Drugs
Table Manufacturing Cost Structure Analysis of Generic Drugs in 2014
Figure Manufacturing Process Analysis of Generic Drugs
Table Capacity (K MT) and Commercial Production Date of Japan Generic Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Japan Key Generic Drugs Manufacturers in 2014
Table R&D Status and Technology Source of Japan Generic Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Japan and Japan Generic Drugs Key Manufacturers in 2014
Table Japan Production of Generic Drugs by Regions 2010-2015 (K MT)
Table Japan Production Market Share of Generic Drugs by Regions 2010-2015 (%)
Figure Japan Production Market Share of Generic Drugs by Regions in 2014
Figure Japan Production Market Share of Generic Drugs by Regions in 2015
Table Japan Production of Generic Drugs by Product Types in 2010-2015 (K MT)
Table Japan Production Market Share of Generic Drugs by Product Types in 2010-2015 (%)
Figure Japan Production Market Share of Generic Drugs by Technology in 2014
Figure Japan Production Market Share of Generic Drugs by Technology in 2015
Figure Japan Sales of Generic Drugs by Applications 2010-2015 (K MT)
Table Japan Production Market Share of Generic Drugs by Applications 2010-2015 (%)
Figure Japan Production Market Share of Generic Drugs by Applications in 2014
Figure Japan Production Market Share of Generic Drugs by Applications in 2015
Table Price Comparison of Japan Generic Drugs Key Manufacturers in 2015 (USD/MT)
Table Japan Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Generic Drugs 2010-2015
Table Japan Sales of Generic Drugs by Regions 2010-2015 (K MT)
Table Japan Sales Market Share of Generic Drugs by Regions 2010-2015 (%)
Figure Japan Sales of Generic Drugs by Regions in 2014 (K MT)
Figure Japan Sales of Generic Drugs by Regions in 2015 (K MT)
Table Japan Revenue of Generic Drugs by Regions 2010-2015 (M USD)
Table Japan Revenue of Generic Drugs by Regions 2010-2015 (%)
Figure Japan Revenue of Generic Drugs by Regions in 2014 (%)
Figure Japan Revenue of Generic Drugs by Regions in 2015 (%)
Table Sales Price of Generic Drugs by Regions 2010-2015 (USD/MT)
Table Japan Price Analysis of Generic Drugs 2010-2015 (USD/MT)
Table Japan Cost Analysis of Generic Drugs 2010-2015 (USD/MT)
Table Japan Gross Analysis of Generic Drugs 2010-2015
Table Japan and Major Manufacturers Capacity of Generic Drugs 2010-2015 (K MT)
Table Japan Capacity Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Table Japan and Major Manufacturers Production of Generic Drugs 2010-2015 (K MT)
Table Japan Production Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Table Japan and Major Manufacturers Sales of Generic Drugs 2010-2015 (K MT)
Table Japan Sales Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Table Japan and Major Manufacturers Sales Revenue of Generic Drugs 2010-2015 (M USD)
Table Japan Sales Revenue Market Share of Major Generic Drugs Manufacturers 2010-2015 (%)
Figure Japan Capacity (K MT), Production (K MT) and Growth Rate of Generic Drugs 2010-2015
Figure Japan Capacity Utilization Rate of Generic Drugs 2010-2015
Figure Japan Sales Revenue (M USD) and Growth Rate of Generic Drugs 2010-2015
Figure Japan Production Market Share of Major Generic Drugs Manufacturers in 2014
Figure Japan Production Market Share of Major Generic Drugs Manufacturers in 2015
Figure Japan Sales Market Share of Major Generic Drugs Manufacturers in 2014
Figure Japan Sales Market Share of Major Generic Drugs Manufacturers in 2015
Table Japan Import, Export and Consumption of Generic Drugs 2010-2015 (K MT)
Table Japan and Major Manufacturers Local Sales Export Import of Generic Drugs 2010-2015 (K MT)
Table Japan Supply, Consumption and Shortage of Generic Drugs 2010-2015 (K MT)
Table Japan Import, Export and Consumption of Generic Drugs 2010-2015 (K MT)
Table Price of Japan Generic Drugs Major Manufacturers 2010-2015 (USD/MT)
Table Gross Margin of Japan Generic Drugs Major Manufacturers 2010-2015
Table Japan and Major Manufacturers Revenue of Generic Drugs 2010-2015 (M USD)
Table Japan Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Generic Drugs 2010-2015
Table Sawai Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Sawai Pharmaceuticals
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Sawai Pharmaceuticals 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Sawai Pharmaceuticals 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Sawai Pharmaceuticals 2010-2015
Table Sawai Pharmaceuticals Generic Drugs SWOT Analysis
Table Meiji Seika Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Meiji Seika Pharma
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Meiji Seika Pharma 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Meiji Seika Pharma 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Meiji Seika Pharma 2010-2015
Table Meiji Seika Pharma Generic Drugs SWOT Analysis
Table Nipro Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Nipro Pharma
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Nipro Pharma 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Nipro Pharma 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Nipro Pharma 2010-2015
Table Nipro Pharma Generic Drugs SWOT Analysis
Table Towa Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Towa Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Towa Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Towa Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Towa Pharmaceutical 2010-2015
Table Towa Pharmaceutical Generic Drugs SWOT Analysis
Table Teva Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Teva Pharmaceutical Industries
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Teva Pharmaceutical Industries 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Teva Pharmaceutical Industries 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Teva Pharmaceutical Industries 2010-2015
Table Teva Pharmaceutical Industries Generic Drugs SWOT Analysis
Table Nichi-Iko Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Nichi-Iko Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Nichi-Iko Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Nichi-Iko Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Nichi-Iko Pharmaceutical 2010-2015
Table Nichi-Iko Pharmaceutical Generic Drugs SWOT Analysis
Table Fuji Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Fuji Pharma
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Fuji Pharma 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Fuji Pharma 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Fuji Pharma 2010-2015
Table Fuji Pharma Generic Drugs SWOT Analysis
Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of GlaxoSmithKline
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of GlaxoSmithKline 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of GlaxoSmithKline 2010-2015
Table GlaxoSmithKline Generic Drugs SWOT Analysis
Table Hikari Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Hikari Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Hikari Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Hikari Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Hikari Pharmaceutical 2010-2015
Table Hikari Pharmaceutical Generic Drugs SWOT Analysis
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Hospira
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Hospira 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Hospira 2010-2015
Table Hospira Generic Drugs SWOT Analysis
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Mylan
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Mylan 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Mylan 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Mylan 2010-2015
Table Mylan Generic Drugs SWOT Analysis
Table Nihon Generic Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Nihon Generic
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Nihon Generic 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Nihon Generic 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Nihon Generic 2010-2015
Table Nihon Generic Generic Drugs SWOT Analysis
Table Nippon Chemipher Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Nippon Chemipher
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Nippon Chemipher 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Nippon Chemipher 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Nippon Chemipher 2010-2015
Table Nippon Chemipher Generic Drugs SWOT Analysis
Table Nippon Kayaku Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Nippon Kayaku
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Nippon Kayaku 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Nippon Kayaku 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Nippon Kayaku 2010-2015
Table Nippon Kayaku Generic Drugs SWOT Analysis
Table Nissin Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Nissin Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Nissin Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Nissin Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Nissin Pharmaceutical 2010-2015
Table Nissin Pharmaceutical Generic Drugs SWOT Analysis
Table Actavis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Actavis
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Actavis 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Actavis 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Actavis 2010-2015
Table Actavis Generic Drugs SWOT Analysis
Table Daiichi Sankyo Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Daiichi Sankyo
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Daiichi Sankyo 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Daiichi Sankyo 2010-2015
Table Daiichi Sankyo Generic Drugs SWOT Analysis
Table Daito Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Daito Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Daito Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Daito Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Daito Pharmaceutical 2010-2015
Table Daito Pharmaceutical Generic Drugs SWOT Analysis
Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Eisai
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Eisai 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Eisai 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Eisai 2010-2015
Table Eisai Generic Drugs SWOT Analysis
Table Ohara Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Ohara Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Ohara Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Ohara Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Ohara Pharmaceutical 2010-2015
Table Ohara Pharmaceutical Generic Drugs SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Pfizer
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Pfizer 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Pfizer 2010-2015
Table Pfizer Generic Drugs SWOT Analysis
Table Sandoz Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Sandoz
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Sandoz 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Sandoz 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Sandoz 2010-2015
Table Sandoz Generic Drugs SWOT Analysis
Table Taiyo Yakuhin Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Taiyo Yakuhin
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Taiyo Yakuhin 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Taiyo Yakuhin 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Taiyo Yakuhin 2010-2015
Table Taiyo Yakuhin Generic Drugs SWOT Analysis
Table Takeda Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Takeda Pharmaceutical
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Takeda Pharmaceutical 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Takeda Pharmaceutical 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Takeda Pharmaceutical 2010-2015
Table Takeda Pharmaceutical Generic Drugs SWOT Analysis
Table Zensei Pharmaceutical Industries Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Generic Drugs Picture and Specifications of Zensei Pharmaceutical Industries
Table Generic Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Zensei Pharmaceutical Industries 2010-2015
Figure Generic Drugs Capacity (K MT), Production (K MT) and Growth Rate of Zensei Pharmaceutical Industries 2010-2015
Figure Generic Drugs Production (K MT) and Japan Market Share of Zensei Pharmaceutical Industries 2010-2015
Table Zensei Pharmaceutical Industries Generic Drugs SWOT Analysis
Table Generic Drugs Price by Regions 2010-2015
Table Generic Drugs Price by Product Types 2010-2015
Table Generic Drugs Price by Company 2010-2015
Table Generic Drugs Gross Margin by Company 2010-2015
Table Price Comparison of Generic Drugs by Regions 2010-2015 (USD/MT)
Table Price of Different Generic Drugs Product Types (USD/MT)
Table Market Share of Different Generic Drugs Price Level
Table Gross Margin of Different Generic Drugs Applications
Table Marketing Channels Status of Generic Drugs
Table Traders or Distributors of Generic Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Generic Drugs (USD/MT)
Table Japan Import, Export, and Trade of Generic Drugs (K MT)
Figure Japan Capacity (K MT), Production (K MT) and Growth Rate of Generic Drugs 2015-2020
Figure Japan Capacity Utilization Rate of Generic Drugs 2015-2020
Table Japan Generic Drugs Production by Product Types 2010-2015 (K MT)
Table Japan Generic Drugs Production Market Share by Product Types 2010-2015 (%)
Figure Japan Production Market Share of Generic Drugs by Technology in 2020
Figure Japan Sales (K MT) and Growth Rate of Generic Drugs 2015-2020
Figure Japan Sales Revenue (Million USD) and Growth Rate of Generic Drugs 2015-2020
Figure Japan Sales of Generic Drugs by Applications 2015-2020 (K MT)
Table Japan Production Market Share of Generic Drugs by Applications 2015-2020 (%)
Figure Japan Production Market Share of Generic Drugs by Applications in 2020
Table Japan Production, Import, Export and Consumption of Generic Drugs 2015-2020 (K MT)
Table Japan Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Generic Drugs 2015-2020
Table Major Raw Materials Suppliers of Generic Drugs with Contact Information
Table Manufacturing Equipment Suppliers of Generic Drugs with Contact Information
Table Major Players of Generic Drugs with Contact Information
Table Key Consumers of Generic Drugs with Contact Information
Table Supply Chain Relationship Analysis of Generic Drugs
Table New Project SWOT Analysis of Generic Drugs
Table New Project Investment Feasibility Analysis of Generic Drugs
Table Part of Interviewees Record List